Molecular epidemiology of enterococcal bacteremia in Australia

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 897-905

  Coombs, Geoffrey W ^a,b   Pearson, Julie C ^a,b   Daley, Denise A ^b   Le, Tam ^b   Robinson, Owen J ^a,b   Gottlie, Thomas ^c   Howden, Benjamin P ^d,e   Johnson, Paul D R ^d   Bennett, Catherine M ^f   Stinear, Timothy P ^d   Turnidge, John D ^g,h  

^a CURTIN UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d AUSTIN HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f DEAKIN UNIVERSITY   (Australia)

^g WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^h UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; LINEZOLID; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ENTEROCOCCUS RAFFINOSUS; EUROPE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; OPERON; PRIORITY JOURNAL; UNITED STATES; VANA GENE; VANB GENE;

ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTEREMIA; COINFECTION; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING;

EID: 84894516656     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03286-13     Document Type: Article

References (34)

1. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, National Healthcare Safety Network Team Participating National Healthcare Safety Network Facilities. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. http://dx.doi.org/10.1086/591861.
2. Pinholt M, Ostergaard C, Arpi M, Bruun NE, Schonheyder HC, Gradel KO, Sogaard M, Knudsen JD, for the Danish Collaborative Bacteraemia Network. 2013. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: A population-based cohort study. Clin. Microbiol. Infect. http://dx.doi.org/10.1111/1469 -0691.12236.
3. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. 2007. Antimicrobial resistance and molecular epidemiology of vancomycinresistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 58:163-170. http://dx.doi.org/10.1016/j.diagmicrobio.2006.12.022. (Pubitemid 46856806)
4. Murray BE. 1990. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3:46-65. (Pubitemid 20078774)
5. Simonsen GS, Smabrekke L, Monnet DL, Sorensen TL, Moller JK, Kristinsson KG, Lagerqvist-Widh A, Torell E, Digranes A, Harthug S, Sundsfjord A. 2003. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J. Antimicrob. Chemother. 51:323-331. http://dx.doi.org/10.1093/jac/dkg052. (Pubitemid 36231152)
6. Treitman AN, Yarnold PR, Warren J, Noskin GA. 2005. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J. Clin. Microbiol. 43:462-463. http://dx.doi.org/10.1128/JCM.43.1.462 -463.2005. (Pubitemid 40096345)
7. Uttley AH, Collins CH, Naidoo J, George RC. 1988. Vancomycinresistant enterococci. Lancet i:57-58.
8. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161. http://dx.doi.org/10.1056/NEJM198807213190307.
9. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, Eisner W, Warren S, Kreiswirth B. 1993. Emergence of vancomycinresistant enterococci in New York City. Lancet 342:76-79. http://dx.doi .org/10.1016/0140-6736(93)91285- T. (Pubitemid 23192423)
10. Murray BE. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721. http://dx.doi.org/10.1056/NEJM200003093421007. (Pubitemid 30131425)
11. Bearman GM, Wenzel RP. 2005. Bacteremias: a leading cause of death. Arch. Med. Res. 36:646-659. http://dx.doi.org/10.1016/j.arcmed.2005.02 .005. (Pubitemid 41436234)
12. Cetinkaya Y, Falk P, Mayhall CG. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707. http://dx.doi.org/10.1128/CMR .13.4.686-707.2000.
13. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. 1995. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125:165-171. http://dx.doi.org/10 .1111/j.1574-6968.1995.tb07353.x.
14. Kamarulzaman A, Tosolini FA, Boquest AL, Geddes JE, Richards MJ. 1995. Vancomycin resistant Enterococcus faecium in a liver transplant recipient. Aust. N. Z. J. Med. 25:560.
15. Bell J, Turnidge J, Coombs G, O'Brien F. 1998. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun. Dis. Intell. 22:249-252.
16. Cooper E, Paull A, O'Reilly M. 2002. Characteristics of a large cluster of vancomycin-resistant enterococci in an Australian hospital. Infect. Control Hosp. Epidemiol. 23:151-153. http://dx.doi.org/10.1086/502027. (Pubitemid 34246544)
17. Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, Kay ID, O'Brien FG, Palladino S, Douglas CR, Montgomery PD, Orrell T, Peterson AM, Kosaras FP, Flexman JP, Heath CH, McCullough CA. 2004. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect. Control Hosp. Epidemiol. 25:384-390. http://dx.doi.org/10.1086/502410. (Pubitemid 38621084)
18. Johnson PD, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Grayson ML, Howden BP. 2010. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. J. Infect. Dis. 202:1278-1286. http://dx.doi.org/10. 1086/656319.
19. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) Investigators MRSA. 2007. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771. http://dx.doi.org/10.1001/ jama.298.15.1763. (Pubitemid 47598444)
20. Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Fosheim G, McDougal LK, Tenover FC. 2006. Community-associated methicillin- resistant Staphylococcus aureus and healthcare risk factors. Emerg. Infect. Dis. 12:1991-1993. http://dx.doi.org/10.3201/eid1212.060505. (Pubitemid 44904946)
21. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Kulski JK, Wilson RD, Bending R, Grubb W. 1998. Antibiotic resistance and genomic analysis of enterococci in an intensive care unit and general wards. Pathol. 30:68-72. http://dx.doi.org/10.1080/00313029800169705. (Pubitemid 28083039)
23. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
24. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, Van Embden JD, Willems RJ. 2002. Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol. 40:1963-1971. http://dx.doi.org /10.1128/JCM.40.6.1963-1971. 2002. (Pubitemid 34596369)
25. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. http://dx.doi.org/10.1086/421946. (Pubitemid 39050477)
26. de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. 2013. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin. Microbiol. Infect. 19:860-868. http://dx.doi.org/10.1111 /1469-0691.12028.
27. Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10:266-278. http://dx.doi.org/10 .1038/nrmicro2761.
28. Iwen PC, Kelly DM, Linder J, Hinrichs SH, Dominguez EA, Rupp ME, Patil KD. 1997. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob. Agents Chemother. 41:494-495. (Pubitemid 27111056)
29. Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC. 2013. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin. Microbiol. Infect. 19:E181-E189. http://dx.doi.org/10.1111/1469 -0691.12132.
30. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ. 2005. Global spread of vancomycinresistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg. Infect. Dis. 11:821-828. http://dx.doi.org/10.3201/1106.041204. (Pubitemid 40720841)
31. Kamolvit W, Sidjabat HE, Nimmo GR, Anuj SN, Bergh H, Richardson LJ, Paterson DL. 2013. Predominance of VREfm ST203 subgroup in Queensland. Pathol. 45:99. http://dx.doi.org/10.1097/PAT.0b013e32835 b68d2.
32. Top J, Willems R, Bonten M. 2008. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS immunol Med. Microbiol. 52:297-308. http://dx.doi.org/10.1111/j.1574-695X.20 08.00383.x. (Pubitemid 351420752)
33. Howden BP, Holt KE, Lam MM, Seemann T, Ballard S, Coombs GW, Tong SY, Grayson ML, Johnson PD, Stinear TP. 2013. Genomic insights to control the emergence of vancomycin-resistant enterococci. mBio 4:eoo412-13. http://dx.doi.org/10.1128/mBio.00412-13.
34. Freitas AR, Tedim AP, Novais C, Ruiz-Garbajosa P, Werner G, Laverde-Gomez JA, Canton R, Peixe L, Baquero F, Coque TM. 2010. Global spread of the hyl(Efm) colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster. Antimicrob. Agents Chemother. 54:2660-2665. http://dx.doi.org/10.1128 /AAC.00134-10.